Global Gastrointestinal OTC Drugs Sales Market Report 2021

Global Gastrointestinal OTC Drugs Sales Market Report 2021

Table of Contents
1 Gastrointestinal OTC Drugs Market Overview
1.1 Gastrointestinal OTC Drugs Product Scope
1.2 Gastrointestinal OTC Drugs Segment by Type
1.2.1 Global Gastrointestinal OTC Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Laxatives
1.2.3 Anti-Flatulents
1.2.4 H2-Antaginists
1.2.5 Anti-Diarrheals
1.2.6 PPIs
1.2.7 Anti-Emetics
1.2.8 Other
1.3 Gastrointestinal OTC Drugs Segment by Application
1.3.1 Global Gastrointestinal OTC Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Gastrointestinal OTC Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Gastrointestinal OTC Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Gastrointestinal OTC Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Gastrointestinal OTC Drugs Price Trends (2016-2027)
2 Gastrointestinal OTC Drugs Estimates and Forecasts by Region
2.1 Global Gastrointestinal OTC Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Gastrointestinal OTC Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Gastrointestinal OTC Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Gastrointestinal OTC Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Gastrointestinal OTC Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Gastrointestinal OTC Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Gastrointestinal OTC Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Gastrointestinal OTC Drugs Estimates and Projections (2016-2027)
2.4.3 China Gastrointestinal OTC Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Gastrointestinal OTC Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Gastrointestinal OTC Drugs Estimates and Projections (2016-2027)
2.4.6 India Gastrointestinal OTC Drugs Estimates and Projections (2016-2027)
3 Global Gastrointestinal OTC Drugs Competition Landscape by Players
3.1 Global Top Gastrointestinal OTC Drugs Players by Sales (2016-2021)
3.2 Global Top Gastrointestinal OTC Drugs Players by Revenue (2016-2021)
3.3 Global Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastrointestinal OTC Drugs as of 2020)
3.4 Global Gastrointestinal OTC Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Gastrointestinal OTC Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Gastrointestinal OTC Drugs Market Size by Type
4.1 Global Gastrointestinal OTC Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Gastrointestinal OTC Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Gastrointestinal OTC Drugs Price by Type (2016-2021)
4.2 Global Gastrointestinal OTC Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Gastrointestinal OTC Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Gastrointestinal OTC Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Gastrointestinal OTC Drugs Price Forecast by Type (2022-2027)
5 Global Gastrointestinal OTC Drugs Market Size by Application
5.1 Global Gastrointestinal OTC Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Gastrointestinal OTC Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Gastrointestinal OTC Drugs Price by Application (2016-2021)
5.2 Global Gastrointestinal OTC Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Gastrointestinal OTC Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Gastrointestinal OTC Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Gastrointestinal OTC Drugs Price Forecast by Application (2022-2027)
6 North America Gastrointestinal OTC Drugs Market Facts & Figures
6.1 North America Gastrointestinal OTC Drugs Sales by Company
6.1.1 North America Gastrointestinal OTC Drugs Sales by Company (2016-2021)
6.1.2 North America Gastrointestinal OTC Drugs Revenue by Company (2016-2021)
6.2 North America Gastrointestinal OTC Drugs Sales Breakdown by Type
6.2.1 North America Gastrointestinal OTC Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Gastrointestinal OTC Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Gastrointestinal OTC Drugs Sales Breakdown by Application
6.3.1 North America Gastrointestinal OTC Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Gastrointestinal OTC Drugs Sales Breakdown by Application (2022-2027)
7 Europe Gastrointestinal OTC Drugs Market Facts & Figures
7.1 Europe Gastrointestinal OTC Drugs Sales by Company
7.1.1 Europe Gastrointestinal OTC Drugs Sales by Company (2016-2021)
7.1.2 Europe Gastrointestinal OTC Drugs Revenue by Company (2016-2021)
7.2 Europe Gastrointestinal OTC Drugs Sales Breakdown by Type
7.2.1 Europe Gastrointestinal OTC Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Gastrointestinal OTC Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Gastrointestinal OTC Drugs Sales Breakdown by Application
7.3.1 Europe 125 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 125 Sales Breakdown by Application (2022-2027)
8 China Gastrointestinal OTC Drugs Market Facts & Figures
8.1 China Gastrointestinal OTC Drugs Sales by Company
8.1.1 China Gastrointestinal OTC Drugs Sales by Company (2016-2021)
8.1.2 China Gastrointestinal OTC Drugs Revenue by Company (2016-2021)
8.2 China Gastrointestinal OTC Drugs Sales Breakdown by Type
8.2.1 China Gastrointestinal OTC Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Gastrointestinal OTC Drugs Sales Breakdown by Type (2022-2027)
8.3 China Gastrointestinal OTC Drugs Sales Breakdown by Application
8.3.1 China 153 Sales Breakdown by Application (2016-2021)
8.3.2 China 153 Sales Breakdown by Application (2022-2027)
9 Japan Gastrointestinal OTC Drugs Market Facts & Figures
9.1 Japan Gastrointestinal OTC Drugs Sales by Company
9.1.1 Japan Gastrointestinal OTC Drugs Sales by Company (2016-2021)
9.1.2 Japan Gastrointestinal OTC Drugs Revenue by Company (2016-2021)
9.2 Japan Gastrointestinal OTC Drugs Sales Breakdown by Type
9.2.1 Japan Gastrointestinal OTC Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Gastrointestinal OTC Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Gastrointestinal OTC Drugs Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Gastrointestinal OTC Drugs Market Facts & Figures
10.1 Southeast Asia Gastrointestinal OTC Drugs Sales by Company
10.1.1 Southeast Asia Gastrointestinal OTC Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Gastrointestinal OTC Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Gastrointestinal OTC Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Gastrointestinal OTC Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Gastrointestinal OTC Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Gastrointestinal OTC Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)
11 India Gastrointestinal OTC Drugs Market Facts & Figures
11.1 India Gastrointestinal OTC Drugs Sales by Company
11.1.1 India Gastrointestinal OTC Drugs Sales by Company (2016-2021)
11.1.2 India Gastrointestinal OTC Drugs Revenue by Company (2016-2021)
11.2 India Gastrointestinal OTC Drugs Sales Breakdown by Type
11.2.1 India Gastrointestinal OTC Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Gastrointestinal OTC Drugs Sales Breakdown by Type (2022-2027)
11.3 India Gastrointestinal OTC Drugs Sales Breakdown by Application
11.3.1 India Gastrointestinal OTC Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Gastrointestinal OTC Drugs Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Gastrointestinal OTC Drugs Business
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Corporation Information
12.1.2 GlaxoSmithKline Business Overview
12.1.3 GlaxoSmithKline Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GlaxoSmithKline Gastrointestinal OTC Drugs Products Offered
12.1.5 GlaxoSmithKline Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Business Overview
12.2.3 Pfizer Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pfizer Gastrointestinal OTC Drugs Products Offered
12.2.5 Pfizer Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Corporation Information
12.3.2 Johnson & Johnson Business Overview
12.3.3 Johnson & Johnson Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Johnson & Johnson Gastrointestinal OTC Drugs Products Offered
12.3.5 Johnson & Johnson Recent Development
12.4 Bayer
12.4.1 Bayer Corporation Information
12.4.2 Bayer Business Overview
12.4.3 Bayer Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Bayer Gastrointestinal OTC Drugs Products Offered
12.4.5 Bayer Recent Development
12.5 Procter & Gamble
12.5.1 Procter & Gamble Corporation Information
12.5.2 Procter & Gamble Business Overview
12.5.3 Procter & Gamble Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Procter & Gamble Gastrointestinal OTC Drugs Products Offered
12.5.5 Procter & Gamble Recent Development
12.6 Perrigo
12.6.1 Perrigo Corporation Information
12.6.2 Perrigo Business Overview
12.6.3 Perrigo Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Perrigo Gastrointestinal OTC Drugs Products Offered
12.6.5 Perrigo Recent Development
12.7 Abbott
12.7.1 Abbott Corporation Information
12.7.2 Abbott Business Overview
12.7.3 Abbott Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Abbott Gastrointestinal OTC Drugs Products Offered
12.7.5 Abbott Recent Development
12.8 Sanofi
12.8.1 Sanofi Corporation Information
12.8.2 Sanofi Business Overview
12.8.3 Sanofi Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Sanofi Gastrointestinal OTC Drugs Products Offered
12.8.5 Sanofi Recent Development
12.9 Teva Pharmaceutical
12.9.1 Teva Pharmaceutical Corporation Information
12.9.2 Teva Pharmaceutical Business Overview
12.9.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Teva Pharmaceutical Gastrointestinal OTC Drugs Products Offered
12.9.5 Teva Pharmaceutical Recent Development
12.10 Nestle
12.10.1 Nestle Corporation Information
12.10.2 Nestle Business Overview
12.10.3 Nestle Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Nestle Gastrointestinal OTC Drugs Products Offered
12.10.5 Nestle Recent Development
12.11 Boehringer Ingelheim
12.11.1 Boehringer Ingelheim Corporation Information
12.11.2 Boehringer Ingelheim Business Overview
12.11.3 Boehringer Ingelheim Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Boehringer Ingelheim Gastrointestinal OTC Drugs Products Offered
12.11.5 Boehringer Ingelheim Recent Development
12.12 Reckitt Benckiser
12.12.1 Reckitt Benckiser Corporation Information
12.12.2 Reckitt Benckiser Business Overview
12.12.3 Reckitt Benckiser Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Reckitt Benckiser Gastrointestinal OTC Drugs Products Offered
12.12.5 Reckitt Benckiser Recent Development
12.13 Purdue Pharma
12.13.1 Purdue Pharma Corporation Information
12.13.2 Purdue Pharma Business Overview
12.13.3 Purdue Pharma Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Purdue Pharma Gastrointestinal OTC Drugs Products Offered
12.13.5 Purdue Pharma Recent Development
13 Gastrointestinal OTC Drugs Manufacturing Cost Analysis
13.1 Gastrointestinal OTC Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Gastrointestinal OTC Drugs
13.4 Gastrointestinal OTC Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Gastrointestinal OTC Drugs Distributors List
14.3 Gastrointestinal OTC Drugs Customers
15 Market Dynamics
15.1 Gastrointestinal OTC Drugs Market Trends
15.2 Gastrointestinal OTC Drugs Drivers
15.3 Gastrointestinal OTC Drugs Market Challenges
15.4 Gastrointestinal OTC Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Gastrointestinal OTC Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Gastrointestinal OTC Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Gastrointestinal OTC Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Gastrointestinal OTC Drugs Sales (K Pcs) by Region (2016-2021)
Table 5. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Gastrointestinal OTC Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Gastrointestinal OTC Drugs Revenue Share by Region (2016-2021)
Table 8. Global Gastrointestinal OTC Drugs Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Gastrointestinal OTC Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Gastrointestinal OTC Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Gastrointestinal OTC Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Gastrointestinal OTC Drugs Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Gastrointestinal OTC Drugs Sales Share by Company (2016-2021)
Table 14. Global Gastrointestinal OTC Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Gastrointestinal OTC Drugs Revenue Share by Company (2016-2021)
Table 16. Global Gastrointestinal OTC Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal OTC Drugs as of 2020)
Table 17. Global Gastrointestinal OTC Drugs Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Gastrointestinal OTC Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Gastrointestinal OTC Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Gastrointestinal OTC Drugs Sales (K Pcs) by Type (2016-2021)
Table 22. Global Gastrointestinal OTC Drugs Sales Share by Type (2016-2021)
Table 23. Global Gastrointestinal OTC Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Gastrointestinal OTC Drugs Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Gastrointestinal OTC Drugs Sales Share by Type (2022-2027)
Table 26. Global Gastrointestinal OTC Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Gastrointestinal OTC Drugs Revenue Share by Type (2022-2027)
Table 28. Global Gastrointestinal OTC Drugs Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Gastrointestinal OTC Drugs Sales (K Pcs) by Application (2016-2021)
Table 30. Global Gastrointestinal OTC Drugs Sales Share by Application (2016-2021)
Table 31. Global Gastrointestinal OTC Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Gastrointestinal OTC Drugs Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Gastrointestinal OTC Drugs Sales (K Pcs) by Application (2022-2027)
Table 34. Global Gastrointestinal OTC Drugs Sales Share by Application (2022-2027)
Table 35. Global Gastrointestinal OTC Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Gastrointestinal OTC Drugs Revenue Share by Application (2022-2027)
Table 37. Global Gastrointestinal OTC Drugs Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Gastrointestinal OTC Drugs Sales (K Pcs) by Company (2016-2021)
Table 39. North America Gastrointestinal OTC Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Gastrointestinal OTC Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Gastrointestinal OTC Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Gastrointestinal OTC Drugs Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Gastrointestinal OTC Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Gastrointestinal OTC Drugs Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Gastrointestinal OTC Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Gastrointestinal OTC Drugs Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Gastrointestinal OTC Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Gastrointestinal OTC Drugs Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Gastrointestinal OTC Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Gastrointestinal OTC Drugs Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Gastrointestinal OTC Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Gastrointestinal OTC Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Gastrointestinal OTC Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Gastrointestinal OTC Drugs Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Gastrointestinal OTC Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Gastrointestinal OTC Drugs Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Gastrointestinal OTC Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Gastrointestinal OTC Drugs Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Gastrointestinal OTC Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Gastrointestinal OTC Drugs Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Gastrointestinal OTC Drugs Sales Market Share by Application (2022-2027)
Table 62. China Gastrointestinal OTC Drugs Sales (K Pcs) by Company (2016-2021)
Table 63. China Gastrointestinal OTC Drugs Sales Market Share by Company (2016-2021)
Table 64. China Gastrointestinal OTC Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Gastrointestinal OTC Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Gastrointestinal OTC Drugs Sales by Type (2016-2021) & (K Pcs)
Table 67. China Gastrointestinal OTC Drugs Sales Market Share by Type (2016-2021)
Table 68. China Gastrointestinal OTC Drugs Sales by Type (2022-2027) & (K Pcs)
Table 69. China Gastrointestinal OTC Drugs Sales Market Share by Type (2022-2027)
Table 70. China Gastrointestinal OTC Drugs Sales by Application (2016-2021) & (K Pcs)
Table 71. China Gastrointestinal OTC Drugs Sales Market Share by Application (2016-2021)
Table 72. China Gastrointestinal OTC Drugs Sales by Application (2022-2027) & (K Pcs)
Table 73. China Gastrointestinal OTC Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Gastrointestinal OTC Drugs Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Gastrointestinal OTC Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Gastrointestinal OTC Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Gastrointestinal OTC Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Gastrointestinal OTC Drugs Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Gastrointestinal OTC Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Gastrointestinal OTC Drugs Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Gastrointestinal OTC Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Gastrointestinal OTC Drugs Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Gastrointestinal OTC Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Gastrointestinal OTC Drugs Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Gastrointestinal OTC Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Gastrointestinal OTC Drugs Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Gastrointestinal OTC Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Gastrointestinal OTC Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Gastrointestinal OTC Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Gastrointestinal OTC Drugs Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Gastrointestinal OTC Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Gastrointestinal OTC Drugs Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Gastrointestinal OTC Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Gastrointestinal OTC Drugs Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Gastrointestinal OTC Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Gastrointestinal OTC Drugs Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Gastrointestinal OTC Drugs Sales Market Share by Application (2022-2027)
Table 98. India Gastrointestinal OTC Drugs Sales (K Pcs) by Company (2016-2021)
Table 99. India Gastrointestinal OTC Drugs Sales Market Share by Company (2016-2021)
Table 100. India Gastrointestinal OTC Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Gastrointestinal OTC Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Gastrointestinal OTC Drugs Sales by Type (2016-2021) & (K Pcs)
Table 103. India Gastrointestinal OTC Drugs Sales Market Share by Type (2016-2021)
Table 104. India Gastrointestinal OTC Drugs Sales by Type (2022-2027) & (K Pcs)
Table 105. India Gastrointestinal OTC Drugs Sales Market Share by Type (2022-2027)
Table 106. India Gastrointestinal OTC Drugs Sales by Application (2016-2021) & (K Pcs)
Table 107. India Gastrointestinal OTC Drugs Sales Market Share by Application (2016-2021)
Table 108. India Gastrointestinal OTC Drugs Sales by Application (2022-2027) & (K Pcs)
Table 109. India Gastrointestinal OTC Drugs Sales Market Share by Application (2022-2027)
Table 110. GlaxoSmithKline Corporation Information
Table 111. GlaxoSmithKline Description and Business Overview
Table 112. GlaxoSmithKline Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. GlaxoSmithKline Gastrointestinal OTC Drugs Product
Table 114. GlaxoSmithKline Recent Development
Table 115. Pfizer Corporation Information
Table 116. Pfizer Description and Business Overview
Table 117. Pfizer Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Pfizer Gastrointestinal OTC Drugs Product
Table 119. Pfizer Recent Development
Table 120. Johnson & Johnson Corporation Information
Table 121. Johnson & Johnson Description and Business Overview
Table 122. Johnson & Johnson Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Johnson & Johnson Gastrointestinal OTC Drugs Product
Table 124. Johnson & Johnson Recent Development
Table 125. Bayer Corporation Information
Table 126. Bayer Description and Business Overview
Table 127. Bayer Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Bayer Gastrointestinal OTC Drugs Product
Table 129. Bayer Recent Development
Table 130. Procter & Gamble Corporation Information
Table 131. Procter & Gamble Description and Business Overview
Table 132. Procter & Gamble Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Procter & Gamble Gastrointestinal OTC Drugs Product
Table 134. Procter & Gamble Recent Development
Table 135. Perrigo Corporation Information
Table 136. Perrigo Description and Business Overview
Table 137. Perrigo Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Perrigo Gastrointestinal OTC Drugs Product
Table 139. Perrigo Recent Development
Table 140. Abbott Corporation Information
Table 141. Abbott Description and Business Overview
Table 142. Abbott Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Abbott Gastrointestinal OTC Drugs Product
Table 144. Abbott Recent Development
Table 145. Sanofi Corporation Information
Table 146. Sanofi Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Sanofi Description and Business Overview
Table 148. Sanofi Gastrointestinal OTC Drugs Product
Table 149. Sanofi Recent Development
Table 150. Teva Pharmaceutical Corporation Information
Table 151. Teva Pharmaceutical Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. Teva Pharmaceutical Description and Business Overview
Table 153. Teva Pharmaceutical Gastrointestinal OTC Drugs Product
Table 154. Teva Pharmaceutical Recent Development
Table 155. Nestle Corporation Information
Table 156. Nestle Description and Business Overview
Table 157. Nestle Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. Nestle Gastrointestinal OTC Drugs Product
Table 159. Nestle Recent Development
Table 160. Boehringer Ingelheim Corporation Information
Table 161. Boehringer Ingelheim Description and Business Overview
Table 162. Boehringer Ingelheim Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. Boehringer Ingelheim Gastrointestinal OTC Drugs Product
Table 164. Boehringer Ingelheim Recent Development
Table 165. Reckitt Benckiser Corporation Information
Table 166. Reckitt Benckiser Description and Business Overview
Table 167. Reckitt Benckiser Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. Reckitt Benckiser Gastrointestinal OTC Drugs Product
Table 169. Reckitt Benckiser Recent Development
Table 170. Purdue Pharma Corporation Information
Table 171. Purdue Pharma Description and Business Overview
Table 172. Purdue Pharma Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 173. Purdue Pharma Gastrointestinal OTC Drugs Product
Table 174. Purdue Pharma Recent Development
Table 175. Production Base and Market Concentration Rate of Raw Material
Table 176. Key Suppliers of Raw Materials
Table 177. Gastrointestinal OTC Drugs Distributors List
Table 178. Gastrointestinal OTC Drugs Customers List
Table 179. Gastrointestinal OTC Drugs Market Trends
Table 180. Gastrointestinal OTC Drugs Market Drivers
Table 181. Gastrointestinal OTC Drugs Market Challenges
Table 182. Gastrointestinal OTC Drugs Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Gastrointestinal OTC Drugs Product Picture
Figure 2. Global Gastrointestinal OTC Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Laxatives Product Picture
Figure 4. Anti-Flatulents Product Picture
Figure 5. H2-Antaginists Product Picture
Figure 6. Anti-Diarrheals Product Picture
Figure 7. PPIs Product Picture
Figure 8. Anti-Emetics Product Picture
Figure 9. Other Product Picture
Figure 10. Global Gastrointestinal OTC Drugs Sales Market Share by Application in 2021 & 2027
Figure 11. Hospital Pharmacies Examples
Figure 12. Retail Pharmacies Examples
Figure 13. Online Pharmacies Examples
Figure 14. Global Gastrointestinal OTC Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Gastrointestinal OTC Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 16. Global Gastrointestinal OTC Drugs Sales (K Pcs) Growth Rate (2016-2027)
Figure 17. Global Gastrointestinal OTC Drugs Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 18. Global Gastrointestinal OTC Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 19. Global Gastrointestinal OTC Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 20. North America Gastrointestinal OTC Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. North America Gastrointestinal OTC Drugs Sales (K Pcs) Growth Rate (2016-2027)
Figure 22. Europe Gastrointestinal OTC Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Europe Gastrointestinal OTC Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 24. China Gastrointestinal OTC Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. China Gastrointestinal OTC Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 26. Japan Gastrointestinal OTC Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Japan Gastrointestinal OTC Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Southeast Asia Gastrointestinal OTC Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. Southeast Asia Gastrointestinal OTC Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 30. India Gastrointestinal OTC Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 31. India Gastrointestinal OTC Drugs Sales (Million USD) Growth Rate (2016-2027)
Figur

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110

According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period. The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......

Global Lansoprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 102

The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......

Global Esomeprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 89

The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 126

Market Overview of Global Irritable Bowel Syndrome (IBS) market: According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......

Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 109

Market Overview of Global Diarrhea Drug market: According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......

Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 96

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......

Global Lansoprazole Professional Survey Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 136

Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......

Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 113

Market Overview of Global Pentasa (Ulcerative Colitis) market: According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs